Biogen Inc (BIIB)
157.13
+1.13
(+0.72%)
USD |
NASDAQ |
Nov 21, 12:50
Biogen Market Cap: 22.90B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 22.73B |
| November 19, 2024 | 22.65B |
| November 18, 2024 | 23.01B |
| November 15, 2024 | 23.31B |
| November 14, 2024 | 24.03B |
| November 13, 2024 | 24.16B |
| November 12, 2024 | 24.52B |
| November 11, 2024 | 25.07B |
| November 08, 2024 | 25.22B |
| November 07, 2024 | 25.34B |
| November 06, 2024 | 25.41B |
| November 05, 2024 | 25.78B |
| November 04, 2024 | 25.29B |
| November 01, 2024 | 25.32B |
| October 31, 2024 | 25.36B |
| October 30, 2024 | 26.40B |
| October 29, 2024 | 26.74B |
| October 28, 2024 | 26.96B |
| October 25, 2024 | 26.47B |
| October 24, 2024 | 26.79B |
| October 23, 2024 | 26.66B |
| October 22, 2024 | 27.09B |
| October 21, 2024 | 26.90B |
| October 18, 2024 | 27.71B |
| October 17, 2024 | 27.62B |
| Date | Value |
|---|---|
| October 16, 2024 | 27.54B |
| October 15, 2024 | 27.91B |
| October 14, 2024 | 27.91B |
| October 11, 2024 | 27.45B |
| October 10, 2024 | 27.48B |
| October 09, 2024 | 27.07B |
| October 08, 2024 | 26.56B |
| October 07, 2024 | 26.71B |
| October 04, 2024 | 27.05B |
| October 03, 2024 | 26.92B |
| October 02, 2024 | 27.50B |
| October 01, 2024 | 27.80B |
| September 30, 2024 | 28.24B |
| September 27, 2024 | 28.36B |
| September 26, 2024 | 28.20B |
| September 25, 2024 | 27.54B |
| September 24, 2024 | 28.28B |
| September 23, 2024 | 28.52B |
| September 20, 2024 | 29.04B |
| September 19, 2024 | 29.34B |
| September 18, 2024 | 28.78B |
| September 17, 2024 | 28.87B |
| September 16, 2024 | 29.07B |
| September 13, 2024 | 28.50B |
| September 12, 2024 | 28.82B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
22.65B
Minimum
Nov 19 2024
62.44B
Maximum
Jun 10 2021
39.18B
Average
39.00B
Median
Aug 01 2023
Market Cap Benchmarks
| Eli Lilly and Co | 709.21B |
| Sage Therapeutics Inc | 304.64M |
| Pfizer Inc | 142.64B |
| Amgen Inc | 155.67B |
| Ionis Pharmaceuticals Inc | 5.492B |
Market Cap Related Metrics
| PE Ratio | 14.19 |
| PS Ratio | 2.387 |
| PEG Ratio | 1.414 |
| Price to Book Value | 1.400 |
| Price to Free Cash Flow | 12.97 |
| Price | 157.13 |
| Earnings Yield | 7.05% |
| PEGY Ratio | 1.414 |
| Operating PE Ratio | 10.30 |
| Normalized PE Ratio | 13.29 |